AI assistant
Structure Therapeutics Inc. — Director's Dealing 2024
Sep 20, 2024
31940_dirs_2024-09-20_e959bad2-7038-44a5-aa9d-d027b29d3d53.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Structure Therapeutics Inc. (GPCR)
CIK: 0001888886
Period of Report: 2024-09-18
Reporting Person: Coll Crespo Blas (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2024-09-18 | Ordinary Shares | A | 90600 | — | Acquired | 102600 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2024-09-18 | Share option (right to buy) | $12.75 | A | 111000 | Acquired | 2034-09-17 | Ordinary Shares (111000) | Direct |
Footnotes
F1: The Ordinary Shares of the Issuer may be represented by American Depositary Shares ('ADSs"). Each ADS represents three Ordinary Shares of the Issuer.
F2: Represents restricted stock unit award granted under the Issuer's 2023 Equity Incentive Plan.
F3: The option exercise price per share is equal to the fair market value per Ordinary Share on the grant date based on the trading price of the Issuer's ADSs.
F4: One-fourth of the shares vest on the first anniversary of September 18, 2024, and the remaining shares shall vest in thirty-six (36) equal monthly installments thereafter.